Dipak Kalita
Senior Vice President Shilpa Pharma Lifesciences Ltd
Seminars
Monday 23rd February 2026
Overcoming the Difficulties in ADC Drug Substance Development with an Integrated Platform
12:00 pm
- Addressing ADC’s multi-component unique chemistries and handling needs, which must be precisely contained and integrated for ADCs to function
- Preserving quality and consistency while moving from lab-scale ADC synthesis to clinical and commercial scale, managed across several outsourcing partners
- Achieving the best possible stability in circulation while guaranteeing effective payload release at the destination
- Advanced analytical techniques are required for ADCs for stability, impurity profiling, DAR distribution, and characterisation
